摘要
【目的】比较关托洛尔、西地兰治疗房性心律失常的有效性及差异性。【方法】81例快速性房性心律失常患者按治疗用药分为美托洛尔组（41例）与西地兰组（40例），分别用两种药物治疗，比较其疗效。【结果】美托洛尔组与西地兰组相比，起效更快[（9．0±4．3）minvs（36．5土12．6）min]，心室率下降幅度更明显（36．12％vs25．21％），治疗有效率更高（93．0％vs69．2％），差异均有显著性（P〈0．05）。两组均无严重不良反应发生。【结论】美托洛尔治疗快速性房性心律失常安全、有效，且较西地兰更为迅速。
[Objective]To compare the efficacy and difference of metoprolol vs cedilanid for the treatment of atrial arrhythmia. [Methods] According to medication, 81 patients with atrial tachyarrhythmia were divided into metoprolol group（ n=41） and cedilanid group（ n =40）. The efficacy was compared between two groups. [Results] Compared with cedilanid group, the onset of the action in metoprolol group was faster[（9.0±4.3） min vs （36.5±12.6）mini, and the ventricular rate decreased more significantly（36.12 %vs 25.21% ）, and the effective rate was higher（93.0% vs 69.2%）. There were significant difference（ P 〈0.05）. No severe side reaction was found in two groups. [Conclusion] Metoprolol for the treatment of atrial tachyarrhythmia is safe and effective, and its onset of the action is faster than cedilanid.
出处
《医学临床研究》
CAS
2011年第1期59-60,共2页
Journal of Clinical Research
